Owing to the unusual clinical presentation in III:3 and the nonsegregating optic atrophy and distinct phenotype in III:2, the CRX variant was thought to not account for the full phenotype and thus the family was recruited into the 100KGP for further investigation. The gene discussed is CRX; the disease is optic atrophy.